CEN Biotech Inc (CENBF)
0.0031
0.00 (0.00%)
USD |
OTCM |
Apr 23, 16:00
CEN Biotech Cash from Operations (TTM): -0.1751M for March 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| March 31, 2023 | -0.1751M |
| December 31, 2022 | -0.3355M |
| September 30, 2022 | -0.5907M |
| June 30, 2022 | -0.4791M |
| March 31, 2022 | -0.3324M |
| December 31, 2021 | -0.3355M |
| September 30, 2021 | -0.1975M |
| June 30, 2021 | -0.3729M |
| March 31, 2021 | -0.2217M |
| December 31, 2020 | -0.3407M |
| September 30, 2020 | -0.7225M |
| June 30, 2020 | -0.7004M |
| March 31, 2020 | -0.9691M |
| December 31, 2019 | -0.8694M |
| September 30, 2019 | -0.8804M |
| Date | Value |
|---|---|
| June 30, 2019 | -1.018M |
| March 31, 2019 | -1.281M |
| December 31, 2018 | -1.724M |
| September 30, 2018 | -2.247M |
| June 30, 2018 | -2.559M |
| March 31, 2018 | -2.204M |
| December 31, 2017 | -2.177M |
| September 30, 2017 | -1.654M |
| June 30, 2017 | -1.141M |
| March 31, 2017 | -1.109M |
| December 31, 2016 | -0.7038M |
| September 30, 2016 | -0.2269M |
| June 30, 2016 | -0.2917M |
| March 31, 2016 | -0.081M |
| December 31, 2015 | -0.2638M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-1.018M
Minimum
Jun 2019
-0.1751M
Maximum
Mar 2023
-0.5338M
Average
-0.426M
Median
Cash from Operations (TTM) Benchmarks
| Rimrock Gold Corp | -0.2986M |
| InMed Pharmaceuticals Inc | -6.337M |
| Venus Concept Inc | -- |
| Juva Life Inc | -5.336M |
| Lucy Scientific Discovery Inc | -5.923M |